ArticleAnnals of medicine and surgery (2012)2026
Paratesticular dedifferentiated liposarcoma with rhabdomyosarcomatous differentiation presenting as hydrocele in an older man: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and clinical importance: Most malignant testicular tumors are germ cell tumors (seminomas and non-seminomatous germ cell tumors), which together account for over 90% of primary testicular cancers and predominate in men aged 15-40 years. In contrast, paratesticular sarcomas such as liposarcoma are rare and typically present in older adults. The paratesticular dedifferentiated liposarcoma (PTDDLPS) subtype is exceptionally uncommon variant, and cases showing heterologous rhabdomyosarcomatous differentiation are exceedingly rare, posing diagnostic and therapeutic challenges. Case presentation: We report a case of 83-year-old man presented with a painless, gradually enlarging left scrotal swelling initially suspected to be a hydrocele. Ultrasonography and MRI demonstrated a heterogeneous paratesticular mass. A high inguinal orchidectomy was performed. Histopathological examination revealed dedifferentiated liposarcoma with extensive rhabdomyosarcomatous differentiation. Immunohistochemistry (IHC) showed myoglobin and MyoD1 positivity in the rhabdomyoblastic component, while MDM2 and CDK4 coexpression and molecular analysis in both lipogenic and sarcomatous areas confirmed the diagnosis. The postoperative course was uneventful and the patient was referred for multidisciplinary follow-up. Clinical discussion: PTDDLP with rhabdomyosarcomatous differentiation in the paratesticular region is extremely rare and can mimic other sarcomas or germ-cell tumors. The correct initial surgical treatment is best performed by high inguinal (radical) orchiectomy with early spermatic cord ligation, which is crucial for minimizing scrotal contamination and local recurrence. Recognition of its biphasic morphology, IHC analysis, supported by molecular testing for MDM2 and CDK4 amplification, is essential for accurate classification and management. Conclusion: This case emphasizes the rarity and highlights the importance of clinicopathological features, diagnostic pitfalls, and prognostic implications considering PTDDLPS with rhabdomyosarcomatous differentiation, reinforces the oncologic importance of a high inguinal approach for suspected malignant paratesticular masses in older men. IHC and molecular analyses are crucial for an accurate diagnosis, particularly in tumors with heterologous elements that may mimic other sarcomas or germ cell tumors. Early recognition and multidisciplinary management optimize local control and surveillance planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.